Pharmacokinetics of cefoperazone in normal volunteers and subjects with renal insufficiency.

AUTOR(ES)

Bolton, W K

RESUMO

We examined the pharmacokinetics of the new beta-lactam agent, cefoperazone, in normal and functionally anephric dialysis subjects with normal liver function. All subjects received 3 g of cefoperazone intravenously, and serial serum and urine samples were taken thereafter for up to 36 h. The serum levels, volume of distribution (0.22 liter/kg, normal; 0.19 liter/kg; dialysis), beta half-life (2.07 h, normal; 2.03 h, dialysis), and total body clearance (96.2 ml/min, normal; 92.9 ml/ min, dialysis) were all not significantly different between the two groups. Cefoperazone may be administered without adjustment of dose for any degree of renal dysfunction to patients with normal hepatic function.

Documentos Relacionados

• Pharmacokinetics of intravenous amdinocillin in healthy subjects and patients with renal insufficiency.
• Cefmenoxime pharmacokinetics in patients with renal insufficiency.
• Pharmacokinetics of habekacin in patients with renal insufficiency.
• Pharmacokinetics of ceftazidime in patients with renal insufficiency.
• Pharmacokinetics of carumonam in patients with renal insufficiency.